TY - JOUR AU - Alobaidi, R. AU - Basu, R. K. AU - Goldstein, S. L. AU - Bagshaw, S. M. PY - 2015 DA - 2015// TI - Sepsis-associated acute kidney injury JO - Semin Nephrol. VL - 35 UR - https://doi.org/10.1016/j.semnephrol.2015.01.002 DO - 10.1016/j.semnephrol.2015.01.002 ID - Alobaidi2015 ER - TY - JOUR AU - Hoste, E. A. AU - Schurgers, M. PY - 2008 DA - 2008// TI - Epidemiology of acute kidney injury: how big is the problem? JO - Crit Care Med. VL - 36 UR - https://doi.org/10.1097/CCM.0b013e318168c590 DO - 10.1097/CCM.0b013e318168c590 ID - Hoste2008 ER - TY - JOUR AU - Kollef, M. H. PY - 2013 DA - 2013// TI - Antibiotics for the critically ill: more than just selecting appropriate initial therapy JO - Crit Care. VL - 17 UR - https://doi.org/10.1186/cc12698 DO - 10.1186/cc12698 ID - Kollef2013 ER - TY - JOUR AU - Roberts, J. A. AU - Kumar, A. AU - Lipman, J. PY - 2017 DA - 2017// TI - Right dose, right now: customized drug dosing in the critically ill JO - Crit Care Med. VL - 45 UR - https://doi.org/10.1097/CCM.0000000000002210 DO - 10.1097/CCM.0000000000002210 ID - Roberts2017 ER - TY - JOUR AU - Leroy, A. AU - Fillastre, J. P. AU - Borsa-Lebas, F. AU - Etienne, I. AU - Humbert, G. PY - 1992 DA - 1992// TI - Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairment JO - Antimicrob Agents Chemother. VL - 36 UR - https://doi.org/10.1128/AAC.36.12.2794 DO - 10.1128/AAC.36.12.2794 ID - Leroy1992 ER - TY - JOUR AU - Breilh, D. AU - Texier-Maugein, J. AU - Allaouchiche, B. AU - Saux, M. C. AU - Boselli, E. PY - 2013 DA - 2013// TI - Carbapenems JO - J Chemother. VL - 25 UR - https://doi.org/10.1179/1973947812Y.0000000032 DO - 10.1179/1973947812Y.0000000032 ID - Breilh2013 ER - TY - JOUR AU - Nicolau, D. P. PY - 2008 DA - 2008// TI - Pharmacokinetic and pharmacodynamic properties of meropenem JO - Clin Infect Dis. VL - 47 UR - https://doi.org/10.1086/590064 DO - 10.1086/590064 ID - Nicolau2008 ER - TY - STD TI - EUCAST. Meropenem Rationale for the EUCAST clinical breakpoints. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Rationale_documents/Meropenem_EUCAST_Rationale_Document_1.5_090601.pdf. Last accessed 11 Nov 2017. UR - http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Rationale_documents/Meropenem_EUCAST_Rationale_Document_1.5_090601.pdf ID - ref8 ER - TY - JOUR AU - Roberts, J. A. AU - Paul, S. K. AU - Akova, M. AU - Bassetti, M. AU - Waele, J. J. AU - Dimopoulos, G. AU - Kaukonen, K. M. AU - Koulenti, D. AU - Martin, C. AU - Montravers, P. AU - Rello, J. AU - Rhodes, A. AU - Starr, T. AU - Wallis, S. C. AU - Lipman, J. PY - 2014 DA - 2014// TI - DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? JO - Clin Infect Dis. VL - 58 UR - https://doi.org/10.1093/cid/ciu027 DO - 10.1093/cid/ciu027 ID - Roberts2014 ER - TY - JOUR AU - Waele, J. J. AU - Lipman, J. AU - Akova, M. AU - Bassetti, M. AU - Dimopoulos, G. AU - Kaukonen, M. AU - Koulenti, D. AU - Martin, C. AU - Montravers, P. AU - Rello, J. AU - Rhodes, A. AU - Udy, A. A. AU - Starr, T. AU - Wallis, S. C. AU - Roberts, J. A. PY - 2014 DA - 2014// TI - Risk factors for target non-attainment during empirical treatment with beta-lactam antibiotics in critically ill patients JO - Intensive Care Med. VL - 40 UR - https://doi.org/10.1007/s00134-014-3403-8 DO - 10.1007/s00134-014-3403-8 ID - Waele2014 ER - TY - JOUR AU - Li, C. AU - Du, X. AU - Kuti, J. L. AU - Nicolau, D. P. PY - 2007 DA - 2007// TI - Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections JO - Antimicrob Agents Chemother. VL - 51 UR - https://doi.org/10.1128/AAC.00294-06 DO - 10.1128/AAC.00294-06 ID - Li2007 ER - TY - JOUR AU - McKinnon, P. S. AU - Paladino, J. A. AU - Schentag, J. J. PY - 2008 DA - 2008// TI - Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections JO - Int J Antimicrob Agents. VL - 31 UR - https://doi.org/10.1016/j.ijantimicag.2007.12.009 DO - 10.1016/j.ijantimicag.2007.12.009 ID - McKinnon2008 ER - TY - JOUR AU - Beumier, M. AU - Casu, G. S. AU - Hites, M. AU - Seyler, L. AU - Cotton, F. AU - Vincent, J. L. AU - Jacobs, F. AU - Taccone, F. S. PY - 2014 DA - 2014// TI - beta-lactam antibiotic concentrations during continuous renal replacement therapy JO - Crit Care VL - 18 UR - https://doi.org/10.1186/cc13886 DO - 10.1186/cc13886 ID - Beumier2014 ER - TY - JOUR AU - Bilgrami, I. AU - Roberts, J. A. AU - Wallis, S. C. AU - Thomas, J. AU - Davis, J. AU - Fowler, S. AU - Goldrick, P. B. AU - Lipman, J. PY - 2010 DA - 2010// TI - Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration JO - Antimicrob Agents Chemother. VL - 54 UR - https://doi.org/10.1128/AAC.01582-09 DO - 10.1128/AAC.01582-09 ID - Bilgrami2010 ER - TY - JOUR AU - Binder, L. AU - Schworer, H. AU - Hoppe, S. AU - Streit, F. AU - Neumann, S. AU - Beckmann, A. AU - Wachter, R. AU - Oellerich, M. AU - Walson, P. D. PY - 2013 DA - 2013// TI - Pharmacokinetics of meropenem in critically ill patients with severe infections JO - Ther Drug Monit. VL - 35 UR - https://doi.org/10.1097/FTD.0b013e31827d496c DO - 10.1097/FTD.0b013e31827d496c ID - Binder2013 ER - TY - JOUR AU - Taccone, F. S. AU - Laterre, P. F. AU - Dugernier, T. AU - Spapen, H. AU - Delattre, I. AU - Wittebole, X. AU - De, B. D. AU - Layeux, B. AU - Wallemacq, P. AU - Vincent, J. L. AU - Jacobs, F. PY - 2010 DA - 2010// TI - Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock JO - Crit Care. VL - 14 UR - https://doi.org/10.1186/cc9091 DO - 10.1186/cc9091 ID - Taccone2010 ER - TY - JOUR AU - Roberts, J. A. AU - Abdul-Aziz, M. H. AU - Lipman, J. AU - Mouton, J. W. AU - Vinks, A. A. AU - Felton, T. W. AU - Hope, W. W. AU - Farkas, A. AU - Neely, M. N. AU - Schentag, J. J. AU - Drusano, G. AU - Frey, O. R. AU - Theuretzbacher, U. AU - Kuti, J. L. PY - 2014 DA - 2014// TI - Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions JO - Lancet Infect Dis. VL - 14 UR - https://doi.org/10.1016/S1473-3099(14)70036-2 DO - 10.1016/S1473-3099(14)70036-2 ID - Roberts2014 ER - TY - JOUR AU - Goncalves-Pereira, J. AU - Povoa, P. PY - 2011 DA - 2011// TI - Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams JO - Crit Care. VL - 15 UR - https://doi.org/10.1186/cc10441 DO - 10.1186/cc10441 ID - Goncalves-Pereira2011 ER - TY - JOUR AU - Mattioli, F. AU - Fucile, C. AU - Del, B. V. AU - Marini, V. AU - Parisini, A. AU - Molin, A. AU - Zuccoli, M. L. AU - Milano, G. AU - Danesi, R. AU - Marchese, A. AU - Polillo, M. AU - Viscoli, C. AU - Pelosi, P. AU - Martelli, A. AU - Di, P. A. PY - 2016 DA - 2016// TI - Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients JO - Eur J Clin Pharmacol VL - 72 UR - https://doi.org/10.1007/s00228-016-2053-x DO - 10.1007/s00228-016-2053-x ID - Mattioli2016 ER - TY - JOUR AU - Roberts, D. M. AU - Liu, X. AU - Roberts, J. A. AU - Nair, P. AU - Cole, L. AU - Roberts, M. S. AU - Lipman, J. AU - Bellomo, R. PY - 2015 DA - 2015// TI - A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics JO - Crit Care. VL - 19 UR - https://doi.org/10.1186/s13054-015-0818-8 DO - 10.1186/s13054-015-0818-8 ID - Roberts2015 ER - TY - JOUR AU - Shaw, A. R. AU - Chaijamorn, W. AU - Mueller, B. A. PY - 2016 DA - 2016// TI - We underdose antibiotics in patients on CRRT JO - Semin Dial. VL - 29 UR - https://doi.org/10.1111/sdi.12496 DO - 10.1111/sdi.12496 ID - Shaw2016 ER - TY - JOUR AU - Ulldemolins, M. AU - Roberts, J. A. AU - Rello, J. AU - Paterson, D. L. AU - Lipman, J. PY - 2011 DA - 2011// TI - The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients JO - Clin Pharmacokinet. VL - 50 UR - https://doi.org/10.2165/11539220-000000000-00000 DO - 10.2165/11539220-000000000-00000 ID - Ulldemolins2011 ER - TY - JOUR AU - Bogard, K. N. AU - Peterson, N. T. AU - Plumb, T. J. AU - Erwin, M. W. AU - Fuller, P. D. AU - Olsen, K. M. PY - 2011 DA - 2011// TI - Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients JO - Crit Care Med. VL - 39 UR - https://doi.org/10.1097/CCM.0b013e318206c3b2 DO - 10.1097/CCM.0b013e318206c3b2 ID - Bogard2011 ER - TY - JOUR AU - Jamal, J. A. AU - Udy, A. A. AU - Lipman, J. AU - Roberts, J. A. PY - 2014 DA - 2014// TI - The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens* JO - Crit Care Med. VL - 42 UR - https://doi.org/10.1097/CCM.0000000000000317 DO - 10.1097/CCM.0000000000000317 ID - Jamal2014 ER - TY - JOUR AU - Jamal, J. A. AU - Mueller, B. A. AU - Choi, G. Y. AU - Lipman, J. AU - Roberts, J. A. PY - 2015 DA - 2015// TI - How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy? JO - Diagn Microbiol Infect Dis. VL - 82 UR - https://doi.org/10.1016/j.diagmicrobio.2015.01.013 DO - 10.1016/j.diagmicrobio.2015.01.013 ID - Jamal2015 ER - TY - JOUR AU - Roberts, D. M. AU - Roberts, J. A. AU - Roberts, M. S. AU - Liu, X. AU - Nair, P. AU - Cole, L. AU - Lipman, J. AU - Bellomo, R. PY - 2012 DA - 2012// TI - Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study JO - Crit Care Med. VL - 40 UR - https://doi.org/10.1097/CCM.0b013e318241e553 DO - 10.1097/CCM.0b013e318241e553 ID - Roberts2012 ER - TY - JOUR AU - Roberts, J. A. AU - Choi, G. Y. AU - Joynt, G. M. AU - Paul, S. K. AU - Deans, R. AU - Peake, S. AU - Cole, L. AU - Stephens, D. AU - Bellomo, R. AU - Turnidge, J. AU - Wallis, S. C. AU - Roberts, M. S. AU - Roberts, D. M. AU - Lassig-Smith, M. AU - Starr, T. AU - Lipman, J. PY - 2016 DA - 2016// TI - SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients JO - BMC Infect Dis. VL - 16 UR - https://doi.org/10.1186/s12879-016-1421-6 DO - 10.1186/s12879-016-1421-6 ID - Roberts2016 ER - TY - JOUR AU - Jorres, A. PY - 2015 DA - 2015// TI - Acute kidney injury: choice of the initial modality for renal replacement therapy JO - Med Klin Intensivmed Notfmed. VL - 110 UR - https://doi.org/10.1007/s00063-015-0024-0 DO - 10.1007/s00063-015-0024-0 ID - Jorres2015 ER - TY - JOUR AU - Mushatt, D. M. AU - Mihm, L. B. AU - Dreisbach, A. W. AU - Simon, E. E. PY - 2009 DA - 2009// TI - Antibiotic dosing in slow extended daily dialysis JO - Clin Infect Dis. VL - 49 UR - https://doi.org/10.1086/600390 DO - 10.1086/600390 ID - Mushatt2009 ER - TY - JOUR AU - Ronco, C. AU - Ricci, Z. AU - De, B. D. AU - Kellum, J. A. AU - Taccone, F. S. AU - Joannidis, M. AU - Pickkers, P. AU - Cantaluppi, V. AU - Turani, F. AU - Saudan, P. AU - Bellomo, R. AU - Joannes-Boyau, O. AU - Antonelli, M. AU - Payen, D. AU - Prowle, J. R. AU - Vincent, J. L. PY - 2015 DA - 2015// TI - Renal replacement therapy in acute kidney injury: controversy and consensus JO - Crit Care. VL - 19 UR - https://doi.org/10.1186/s13054-015-0850-8 DO - 10.1186/s13054-015-0850-8 ID - Ronco2015 ER - TY - JOUR AU - Caires, R. A. AU - Abdulkader, R. C. AU - Costa, E. AU - Silva, V. T. AU - Ferreira, G. S. AU - Burdmann, E. A. AU - Yu, L. AU - Macedo, E. PY - 2016 DA - 2016// TI - Sustained low-efficiency extended dialysis (SLED) with single-pass batch system in critically-ill patients with acute kidney injury (AKI) JO - J Nephrol. VL - 29 UR - https://doi.org/10.1007/s40620-015-0224-y DO - 10.1007/s40620-015-0224-y ID - Caires2016 ER - TY - JOUR AU - Villa, G. AU - Neri, M. AU - Bellomo, R. AU - Cerda, J. AU - Gaudio, A. R. AU - De, R. S. AU - Garzotto, F. AU - Honore, P. M. AU - Kellum, J. AU - Lorenzin, A. AU - Payen, D. AU - Ricci, Z. AU - Samoni, S. AU - Vincent, J. L. AU - Wendon, J. AU - Zaccaria, M. AU - Ronco, C. PY - 2016 DA - 2016// TI - Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications JO - Crit Care. VL - 20 UR - https://doi.org/10.1186/s13054-016-1456-5 DO - 10.1186/s13054-016-1456-5 ID - Villa2016 ER - TY - JOUR AU - Fieghen, H. E. AU - Friedrich, J. O. AU - Burns, K. E. AU - Nisenbaum, R. AU - Adhikari, N. K. AU - Hladunewich, M. A. AU - Lapinsky, S. E. AU - Richardson, R. M. AU - Wald, R. PY - 2010 DA - 2010// TI - The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury JO - BMC Nephrol. VL - 11 UR - https://doi.org/10.1186/1471-2369-11-32 DO - 10.1186/1471-2369-11-32 ID - Fieghen2010 ER - TY - JOUR AU - Mei, J. P. AU - Ali-Moghaddam, A. AU - Mueller, B. A. PY - 2016 DA - 2016// TI - Survey of pharmacists' antibiotic dosing recommendations for sustained low-efficiency dialysis JO - Int J Clin Pharm. VL - 38 UR - https://doi.org/10.1007/s11096-015-0214-0 DO - 10.1007/s11096-015-0214-0 ID - Mei2016 ER - TY - JOUR AU - Harris, L. E. AU - Reaves, A. B. AU - Krauss, A. G. AU - Griner, J. AU - Hudson, J. Q. PY - 2013 DA - 2013// TI - Evaluation of antibiotic prescribing patterns in patients receiving sustained low-efficiency dialysis: opportunities for pharmacists JO - Int J Pharm Pract. VL - 21 UR - https://doi.org/10.1111/j.2042-7174.2012.00226.x DO - 10.1111/j.2042-7174.2012.00226.x ID - Harris2013 ER - TY - JOUR AU - Roberts, J. A. AU - Mehta, R. L. AU - Lipman, J. PY - 2011 DA - 2011// TI - Sustained low efficiency dialysis allows rational renal replacement therapy, but does it allow rational drug dosing? JO - Crit Care Med. VL - 39 UR - https://doi.org/10.1097/CCM.0b013e31820e6a0d DO - 10.1097/CCM.0b013e31820e6a0d ID - Roberts2011 ER - TY - JOUR AU - Roberts, J. A. AU - Roberts, D. M. PY - 2014 DA - 2014// TI - Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines? JO - Crit Care. VL - 18 UR - https://doi.org/10.1186/cc13939 DO - 10.1186/cc13939 ID - Roberts2014 ER - TY - JOUR AU - Deshpande, P. AU - Chen, J. AU - Gofran, A. AU - Murea, M. AU - Golestaneh, L. PY - 2010 DA - 2010// TI - Meropenem removal in critically ill patients undergoing sustained low-efficiency dialysis (SLED) JO - Nephrol Dial Transplant. VL - 25 UR - https://doi.org/10.1093/ndt/gfq090 DO - 10.1093/ndt/gfq090 ID - Deshpande2010 ER - TY - JOUR AU - Kielstein, J. T. AU - Czock, D. AU - Schopke, T. AU - Hafer, C. AU - Bode-Boger, S. M. AU - Kuse, E. AU - Keller, F. AU - Fliser, D. PY - 2006 DA - 2006// TI - Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis JO - Crit Care Med. VL - 34 UR - https://doi.org/10.1097/01.CCM.0000190243.88133.3F DO - 10.1097/01.CCM.0000190243.88133.3F ID - Kielstein2006 ER - TY - JOUR AU - Elkhaili, H. AU - Niedergang, S. AU - Pompei, D. AU - Linger, L. AU - Leveque, D. AU - Jehl, F. PY - 1996 DA - 1996// TI - High-performance liquid chromatographic assay for meropenem in serum JO - J Chromatogr B Biomed Appl. VL - 686 UR - https://doi.org/10.1016/S0378-4347(96)00205-8 DO - 10.1016/S0378-4347(96)00205-8 ID - Elkhaili1996 ER - TY - STD TI - US Food and Drug Administration. Guidance for Industry Bioanalytical Method Validation. http://www.fda.gov/downloads/Drugs/Guidance/ucm070107.pdf. Last accessed 11 Nov 2017. UR - http://www.fda.gov/downloads/Drugs/Guidance/ucm070107.pdf ID - ref41 ER - TY - JOUR AU - Neely, M. N. AU - Guilder, M. G. AU - Yamada, W. M. AU - Schumitzky, A. AU - Jelliffe, R. W. PY - 2012 DA - 2012// TI - Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R JO - Ther Drug Monit. VL - 34 UR - https://doi.org/10.1097/FTD.0b013e31825c4ba6 DO - 10.1097/FTD.0b013e31825c4ba6 ID - Neely2012 ER - TY - JOUR AU - Tatarinova, T. AU - Neely, M. AU - Bartroff, J. AU - Guilder, M. AU - Yamada, W. AU - Bayard, D. AU - Jelliffe, R. AU - Leary, R. AU - Chubatiuk, A. AU - Schumitzky, A. PY - 2013 DA - 2013// TI - Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian JO - J Pharmacokinet Pharmacodyn. VL - 40 UR - https://doi.org/10.1007/s10928-013-9302-8 DO - 10.1007/s10928-013-9302-8 ID - Tatarinova2013 ER - TY - STD TI - Jamal JA, Mat-Nor MB, Mohamad-Nor FS, Udy AA, Wallis SC, Lipman J, Roberts JA. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration. Int J Antimicrob Agents. 2015;45:41–5 ID - ref44 ER - TY - JOUR AU - Krueger, W. A. AU - Schroeder, T. H. AU - Hutchison, M. AU - Hoffmann, E. AU - Dieterich, H. J. AU - Heininger, A. AU - Erley, C. AU - Wehrle, A. AU - Unertl, K. PY - 1998 DA - 1998// TI - Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration JO - Antimicrob Agents Chemother. VL - 42 ID - Krueger1998 ER - TY - JOUR AU - Giles, L. J. AU - Jennings, A. C. AU - Thomson, A. H. AU - Creed, G. AU - Beale, R. J. AU - McLuckie, A. PY - 2000 DA - 2000// TI - Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration JO - Crit Care Med. VL - 28 UR - https://doi.org/10.1097/00003246-200003000-00005 DO - 10.1097/00003246-200003000-00005 ID - Giles2000 ER - TY - JOUR AU - Afshartous, D. AU - Bauer, S. R. AU - Connor, M. J. AU - Aduroja, O. A. AU - Amde, M. AU - Salem, C. AU - Groszek, J. J. AU - Fissell, W. H. PY - 2014 DA - 2014// TI - Pharmacokinetics and pharmacodynamics of imipenem and meropenem in critically ill patients treated with continuous venovenous hemodialysis JO - Am J Kidney Dis. VL - 63 UR - https://doi.org/10.1053/j.ajkd.2013.08.015 DO - 10.1053/j.ajkd.2013.08.015 ID - Afshartous2014 ER - TY - JOUR AU - Christensson, B. A. AU - Nilsson-Ehle, I. AU - Hutchison, M. AU - Haworth, S. J. AU - Oqvist, B. AU - Norrby, S. R. PY - 1992 DA - 1992// TI - Pharmacokinetics of meropenem in subjects with various degrees of renal impairment JO - Antimicrob Agents Chemother. VL - 36 UR - https://doi.org/10.1128/AAC.36.7.1532 DO - 10.1128/AAC.36.7.1532 ID - Christensson1992 ER - TY - JOUR AU - Chimata, M. AU - Nagase, M. AU - Suzuki, Y. AU - Shimomura, M. AU - Kakuta, S. PY - 1993 DA - 1993// TI - Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease JO - Antimicrob Agents Chemother. VL - 37 UR - https://doi.org/10.1128/AAC.37.2.229 DO - 10.1128/AAC.37.2.229 ID - Chimata1993 ER - TY - JOUR AU - Ulldemolins, M. AU - Soy, D. AU - Llaurado-Serra, M. AU - Vaquer, S. AU - Castro, P. AU - Rodriguez, A. H. AU - Pontes, C. AU - Calvo, G. AU - Torres, A. AU - Martin-Loeches, I. PY - 2015 DA - 2015// TI - Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements JO - Antimicrob Agents Chemother. VL - 59 UR - https://doi.org/10.1128/AAC.00712-15 DO - 10.1128/AAC.00712-15 ID - Ulldemolins2015 ER - TY - JOUR AU - Roberts, J. A. AU - Kirkpatrick, C. M. AU - Roberts, M. S. AU - Robertson, T. A. AU - Dalley, A. J. AU - Lipman, J. PY - 2009 DA - 2009// TI - Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution JO - J Antimicrob Chemother. VL - 64 UR - https://doi.org/10.1093/jac/dkp139 DO - 10.1093/jac/dkp139 ID - Roberts2009 ER - TY - JOUR AU - Slama, T. G. PY - 2008 DA - 2008// TI - Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use JO - Crit Care. VL - 12 UR - https://doi.org/10.1186/cc6994 DO - 10.1186/cc6994 ID - Slama2008 ER - TY - JOUR AU - Huttner, A. AU - Harbarth, S. AU - Hope, W. W. AU - Lipman, J. AU - Roberts, J. A. PY - 2015 DA - 2015// TI - Therapeutic drug monitoring of the beta-lactam antibiotics: what is the evidence and which patients should we be using it for? JO - J Antimicrob Chemother. VL - 70 ID - Huttner2015 ER -